Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
UMass Chan Affiliations
Department of Cell Biology and NeurologyGraduate School of Biomedical Sciences
Document Type
Journal ArticlePublication Date
2008-10-30Keywords
Animals; Biological Transport, Active; Brain; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Neurites; Neuronal Plasticity; RNA, Messenger; Receptors, Metabotropic Glutamate; Synaptic TransmissionLife Sciences
Medicine and Health Sciences
Metadata
Show full item recordAbstract
Fragile X syndrome is the most common inherited form of cognitive deficiency in humans and perhaps the best-understood single cause of autism. A trinucleotide repeat expansion, inactivating the X-linked FMR1 gene, leads to the absence of the fragile X mental retardation protein. FMRP is a selective RNA-binding protein that regulates the local translation of a subset of mRNAs at synapses in response to activation of Gp1 metabotropic glutamate receptors (mGluRs) and possibly other receptors. In the absence of FMRP, excess and dysregulated mRNA translation leads to altered synaptic function and loss of protein synthesis-dependent plasticity. Recent evidence indicates the role of FMRP in regulated mRNA transport in dendrites. New studies also suggest a possible local function of FMRP in axons that may be important for guidance, synaptic development, and formation of neural circuits. The understanding of FMRP function at synapses has led to rationale therapeutic approaches.Source
Neuron. 2008 Oct 23;60(2):201-14. Link to article on publisher's siteDOI
10.1016/j.neuron.2008.10.004Permanent Link to this Item
http://hdl.handle.net/20.500.14038/32856PubMed ID
18957214Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.neuron.2008.10.004